Life Tech to Distribute Aruna Cell Products | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies will distribute Aruna Biomedical's human embryonic stem cell-derived neural products, under a non-exclusive, multi-year agreement announced today by Athens, Ga.-based Aruna.

Aruna said that Life Technologies will provide the neural products and will be able to provide customized screening services using Aruna products and technologies. The firm said that other human cellular products may be added to the pact in the future.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.